India Glycols’ Unsecured Creditors Clear Scheme Resolution Under NCLT Supervision

The latest update is out from India Glycols Limited ( (IN:INDIAGLYCO) ).

India Glycols Limited reported the outcome of a court-convened meeting of its unsecured creditors held via video conference on 24 March 2026, as directed by the National Company Law Tribunal, Allahabad Bench. The meeting, attended by 27 unsecured creditors, concerned a scheme of arrangement among India Glycols, Ennature Bio Pharma and IGL Spirits and followed all applicable Companies Act and SEBI listing regulations.

The company disclosed that voting results and the consolidated scrutinizer’s report have been finalized and made available on its and NSDL’s websites. A single resolution related to the scheme of arrangement was passed with the requisite majority, marking a key procedural milestone that advances the court-supervised reorganization of the group’s businesses and could influence creditor protections and the company’s future corporate structure.

More about India Glycols Limited

India Glycols Limited operates in the chemicals and bio-based products industry, with activities spanning specialty chemicals, spirits and bio-pharma ingredients through group entities such as Ennature Bio Pharma Limited and IGL Spirits Limited. The company caters to industrial customers and consumer-facing sectors, and is pursuing a court-approved scheme of arrangement among its group companies to streamline structure and stakeholder interests.

Average Trading Volume: 6,276

Technical Sentiment Signal: Buy

Current Market Cap: 54.85B INR

For detailed information about INDIAGLYCO stock, go to TipRanks’ Stock Analysis page.